自噬
非酒精性脂肪肝
细胞凋亡
MAPK/ERK通路
脂肪肝
活性氧
癌症研究
蛋白激酶A
信号转导
没食子酸表没食子酸酯
药理学
生物
细胞生物学
化学
激酶
内科学
医学
生物化学
抗氧化剂
疾病
多酚
作者
Dongdong Wu,Zhengguo Liu,Yizhen Wang,Qianqian Zhang,Jian‐Mei Li,Peiyu Zhong,Zhongwen Xie,Ailing Ji,Yanzhang Li
摘要
Nonalcoholic fatty liver disease (NAFLD) represents one of the most common chronic liver diseases in the world. It has been reported that epigallocatechin‐3‐gallate (EGCG) plays important biological and pharmacological roles in mammalian cells. Nevertheless, the mechanism underlying the beneficial effect of EGCG on the progression of NAFLD has not been fully elucidated. In the present study, the mechanisms of action of EGCG on the growth, apoptosis, and autophagy were examined using oleic acid‐ (OA‐) treated liver cells and the high‐fat diet‐ (HFD‐) induced NAFLD mouse model. Administration of EGCG promoted the growth of OA‐treated liver cells. EGCG could reduce mitochondrial‐dependent apoptosis and increase autophagy possibly via the reactive oxygen species‐ (ROS‐) mediated mitogen‐activated protein kinase (MAPK) pathway in OA‐treated liver cells. In line with in vitro findings, our in vivo study verified that treatment with EGCG attenuated HFD‐induced NAFLD through reduction of apoptosis and promotion of autophagy. EGCG can alleviate HFD‐induced NAFLD possibly by decreasing apoptosis and increasing autophagy via the ROS/MAPK pathway. EGCG may be a promising agent for the treatment of NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI